The Expression Status and Prognostic Value of Cancer Stem Cell Biomarker CD133 in Cutaneous Squamous Cell Carcinoma | Zendy

Rui Xu | Zendy; Mu-Yan Cai | Zendy; Rong-Zhen Luo | Zendy; Xin Tian | Zendy; Jian-de Han | Zendy; Mu-Kai Chen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Expression Status and Prognostic Value of Cancer Stem Cell Biomarker CD133 in Cutaneous Squamous Cell Carcinoma

Author(s) -

Rui Xu,

Mu-Yan Cai,

Rong-Zhen Luo,

Xin Tian,

Jian-de Han,

Mu-Kai Chen

Publication year - 2015

Publication title -

jama dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.128

H-Index - 166

eISSN - 2168-6084

pISSN - 2168-6068

DOI - 10.1001/jamadermatol.2015.3781

Subject(s) - tissue microarray , medicine , biomarker , immunohistochemistry , cancer , cancer stem cell , pathology , oncology , receiver operating characteristic , proportional hazards model , survival analysis , stem cell marker , cancer research , stem cell , biology , biochemistry , genetics

The CD133 protein has been considered a key biomarker of cancer stem cells in various cancers. However, the expression status and prognostic significance of CD133 in cutaneous squamous cell carcinoma (cSCC) are poorly understood.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research